MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (L38972) - R1 - Effective April 18, 2024

Date Posted: April 18, 2024

This Local Coverage Determination (LCD) has been revised under contractor numbers: 01111 (CA), 01211 (AS, GU, HI, NMI), 01311 (NV), and 01911 (CA, HI & Territories).

Effective Date: April 18, 2024

Summary of Changes:

Under CMS National Coverage Policy updated section heading for 2nd regulation. Under Bibliography changes were made to citation to reflect AMA citation guidelines. Formatting, punctuation, and typographical errors were corrected throughout the LCD.

Visit the Active LCDs webpage to view the Active LCD or access it via the CMS MCD.

Last Updated Apr 18 , 2024